JAMP SULFASALAZINE DIN 02544652
Health Canada record
| Active ingredient(s) | SULFASALAZINE 500 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A07EC01 SULFASALAZINE |
| Original market date | 10-Dec-2025 |
| Current status date | 10-Dec-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SULFASALAZINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00598461 | PMS-SULFASALAZINE 500MG/TAB USP | PHARMASCIENCE INC | Tablet | SULFASALAZINE 500 MG | Marketed |
| 00598488 | PMS-SULFASALAZINE-E.C. TAB 500MG | PHARMASCIENCE INC | Tablet (Enteric-Coated) | SULFASALAZINE 500 MG | Marketed |
| 02064472 | SALAZOPYRIN EN-TABS 500 MG | PFIZER CANADA ULC | Tablet (Enteric-Coated) | SULFASALAZINE 500 MG | Marketed |
| 02064480 | SALAZOPYRIN TAB 500MG | PFIZER CANADA ULC | Tablet | SULFASALAZINE 500 MG | Marketed |
| 00410640 | APO SULFASALAZINE TAB 500MG | APOTEX INC | Tablet | SULFASALAZINE 500 MG | Cancelled Post Market |
| 02246803 | ORB-SULFASALAZINE EC | ORBUS PHARMA INC | Tablet (Enteric-Coated) | SULFASALAZINE 500 MG | Cancelled (Unreturned Annual) |
| 00685925 | RATIO-SULFASALAZINE EN | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet (Enteric-Coated) | SULFASALAZINE 500 MG | Cancelled Post Market |
| 00685933 | RATIO-SULFASALAZINE TAB 500MG | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | Tablet | SULFASALAZINE 500 MG | Cancelled Post Market |
| 00445126 | S.A.S. ENTERIC 500MG | ICN CANADA LTD. | Tablet (Enteric-Coated) | SULFASALAZINE 500 MG | Cancelled Post Market |
| 02004682 | SALAZOPYRIN ENEMA 3.0GM/100ML | KABI PHARMACIA CANADA INC. | Suspension | SULFASALAZINE 3 G | Cancelled Post Market |
| 02064499 | SALAZOPYRIN ENEMA 3GM/100ML | PFIZER CANADA ULC | Enema | SULFASALAZINE 3 G | Cancelled Post Market |
| 00613568 | SAS ENEMA 3GM/100ML | ICN CANADA LTD. | Enema | SULFASALAZINE 3 G | Cancelled Post Market |
| 00263869 | SAS TAB 500MG | ICN CANADA LTD. | Tablet | SULFASALAZINE 500 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 32559 | 2024-01-18 | Abbreviated New Drug Submission (ANDS) |
International API supply for SULFASALAZINE
3 valid EDQM Certificates of Suitability from 3 holders. 4 active FDA Drug Master Files.
Request a quote for JAMP SULFASALAZINE